Access the full text.
Sign up today, get DeepDyve free for 14 days.
Reinier Alvarez, R. Kotecha, M. McDermott, V. Siomin (2021)
Awake craniotomy for glioblastoma in COVID-19–positive patients and delivering the standard of care: illustrative caseJournal of Neurosurgery: Case Lessons, 2
R. Beyrouti, M. Adams, L. Benjamin, H. Cohen, S. Farmer, Y. Goh, F. Humphries, H. Jäger, N. Losseff, R. Perry, Sachit Shah, R. Simister, David Turner, A. Chandratheva, D. Werring (2020)
Characteristics of ischaemic stroke associated with COVID-19Journal of Neurology, Neurosurgery, and Psychiatry, 91
(2021)
Dovezi stiintifice. Experiente proprii
Cuiwei Liu, Yanxia Zhao, D. Okwan-Duodu, R. Basho, Xiaojiang Cui (2020)
COVID-19 in cancer patients: risk, clinical features, and managementCancer Biology & Medicine, 17
(2021)
Med Mark -Boli Infect
Milton Budoff, Tamara Martin, Amanda Chow (2014)
National Institute Of Neurological Disorders And Stroke
Malik Ghannam, Qasem Alshaer, Mustafa Al-Chalabi, Lara Zakarna, Jetter Robertson, G. Manousakis (2020)
Neurological involvement of coronavirus disease 2019: a systematic reviewJournal of Neurology, 267
(2020)
Infectia cu coronavirus (SARS-CoV0-2) Situatia la nivel global, actualizata zilnic CNSCBT: INSP
(2021)
Infectia cu SARS-CoV2. In: Boli infecțioase și epidemiologie – note de curs, vol II. Constanta: Ovidius
L. Mao, Huijuan Jin, Mengdie Wang, Yu Hu, Shengcai Chen, Quanwei He, Jiang Chang, Can-dong Hong, Yifan Zhou, David Wang, Xiao-ping Miao, Ya-nan Li, Bo Hu (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.JAMA neurology
S. Nannoni, R. Groot, S. Bell, H. Markus (2020)
Stroke in COVID-19: A systematic review and meta-analysisInternational Journal of Stroke, 16
A. Merkler, N. Parikh, Saad Mir, Ajay Gupta, H. Kamel, E. Lin, J. Lantos, E. Schenck, P. Goyal, Samuel Bruce, J. Kahan, Kelsey Lansdale, Natalie LeMoss, S. Murthy, P. Stieg, M. Fink, C. Iadecola, A. Segal, Marika Cusick, T. Campion, Iván Díaz, Cenai Zhang, B. Navi (2020)
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.JAMA neurology
G. Tsivgoulis, L. Palaiodimou, R. Zand, V. Lioutas, C. Krogias, A. Katsanos, A. Shoamanesh, V. Sharma, S. Shahjouei, C. Baracchini, C. Vlachopoulos, R. Gournellis, P. Sfikakis, E. Sandset, A. Alexandrov, S. Tsiodras (2020)
COVID-19 and cerebrovascular diseases: a comprehensive overviewTherapeutic Advances in Neurological Disorders, 13
AbstractSARS-CoV-2 (severe acute respiratory syndrome), rapidly escalated to a pandemic and has a significant impact on the quality of human life and activity, affecting millions of people.The presentation resumes data regarding the neurological impairment of patients affected by COVID-19; although the data was observational and limited, this examination would help us to broaden our understanding on the association between COVID-19 and the stroke. In order to support such observations I will present two cases of patients diagnosed with COVID-19 that have shown neurological damage, but with different altogether outcomes.The first case analysed, the age and comorbidities of the patient determined an unfavourable evolution, partly also due to tardiness in getting admitted. The apparition of the stroke after the serological negative bias SARS-CoV-2 denotes the complications recently emerged after the severe infection with COV-2, therefore while the viral infection remitted, the physical and pathological tumult determined the emergence of complications with unfavourable evolution. Although similar in certain ways to the first case, the second patient that also presented multiple unfavourable factors, such as old age, severe comorbidities and beyond that - multiple hospital admissions, recent neurosurgical intervention- clinical, immune-serum and biological evolutions have been favourable.Cerebrovascular events are somewhat common findings in COVID-19 infected patients and they could bare a multifactorial etiology. In order to better understand the impact of cerebrovascular events in COVID-19 infection, more precise and prospective data are needed.
ARS Medica Tomitana – de Gruyter
Published: Nov 1, 2020
Keywords: COVID-19; SARS-CoV-2; stroke; comorbidities; evolution
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.